January 2008

Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelopdysplastic Syndrome

Conditions: Myelodysplastic Syndrome (MDS); Severe Aplastic Anemia (SAA)
Interventions: Other: Umbilical Cord Blood; Other: Haploidentical Stem Cells; Device: Miltenvi CliniMACs CD34 Reagent System
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified December 6, 2016

Phase 2 Haplotype Mismatched HSCT in Patients With Hematological Malignancies

Conditions: Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Myelodysplasia; Chronic Myeloid Leukemia
Interventions: Radiation: Total Body Irradiation; Drug: Thiotepa; Drug: Fludarabine; Biological: Rabbit ATG; Drug: Palifermin
Sponsor: Sherif S. Farag
Terminated - verified January 2017

January 2008

Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelopdysplastic Syndrome

Phase 2 Haplotype Mismatched HSCT in Patients With Hematological Malignancies

Keep in touch

Be a team player

Learn about ALS

Get help

You are here

January 2008

Keep in touch

Be a team player

Learn about ALS

Get help